Month: January 2026

Avoiding Fraud in Mass Torts
January 25, 2026 by Mohr Marketing “Cheap” Leads Ruining Your Docket? Avoiding Fraud in Mass Torts Looking to increase capacity in active MDLs? This video details how Mohr Marketing delivers high-quality, fully screened, retention-ready MDL intake without the risk of fraud. We specialize in navigating the surge of Mass Tort litigation by utilizing SEC-level security standards. We ensure your firm avoids… Continue reading Avoiding Fraud in Mass Torts
Compliant Legal Leads Fradulent Claims
Navigating the MDL Surge: Why Compliance Defines Case Quality
January 24, 2026 by Mohr Marketing With Multidistrict Litigation (MDL) dockets expanding rapidly—including over 67k+ cases for J&J Talc alone—law firms face a critical challenge: How do you scale volume without polluting your docket with fraudulent claims? In this video, we explore the high cost of “cheap” leads and why Mohr Marketing has adopted a compliance-first approach to Mass Tort intake.… Continue reading Navigating the MDL Surge: Why Compliance Defines Case Quality
Compliance Program Fraudulent Claims Lead Fraud
Why Smart Firms Are Switching to AI-Powered Marketing Support
January 23, 2026 by Mohr Marketing The “Signed Case” is Dead: Why Smart Firms Are Switching to AI-Powered Marketing Support Legal Marketing / Ethics & Compliance For years, the “Holy Grail” of personal injury marketing was the “Signed Case”—a neat little package where a vendor did everything, including signing the retainer, and handed it to the attorney. But in 2026, that… Continue reading Why Smart Firms Are Switching to AI-Powered Marketing Support
AI and Lead Generation Compliance Program
MARKET BRIEF: THE 2026 HERNIA MESH PIVOT
January 22, 2026 by Mohr Marketing Allocation Strategy: Bard (MDL 2846) vs. Covidien (MDL 3029) EXECUTIVE SUMMARY The “Hernia Mesh” bucket is no longer a single asset class. As we enter Q1 2026, the litigation has bifurcated into two distinct phases. Bard has transitioned into a mature “Administration & Cleanup” phase, where value is found only in specific, high-damage claims. Covidien,… Continue reading MARKET BRIEF: THE 2026 HERNIA MESH PIVOT
Bard Hernia Mesh Litigation Covidien Litigation
Solving the “Fake Lead” Crisis in Mass Torts with AI
January 22, 2026 by Mohr Marketing The end of the “Lead Broker” model in MDLs With MDL judges increasingly scrutinizing plaintiff inventories and defense counsel flagging “bot” submissions in high-profile torts, the integrity of legal lead generation is facing a crisis. I am writing to share how Mohr Marketing is addressing this head-on. We have moved away from the traditional “Lead… Continue reading Solving the “Fake Lead” Crisis in Mass Torts with AI
Leads for Attorneys legal marketing
The Bard Hernia Mesh Landscape in 2026
January 21, 2026 by Mohr Marketing Bard Settlement vs. Covidien Growth: Where to Put Your Budget in 2026 For the last five years, MDL 2846 (In re: Davol, Inc./C.R. Bard, Inc.) has been a cornerstone of many mass tort inventories. However, following Becton Dickinson’s October 2024 announcement of a global settlement framework (approx. $1.9 billion reserved for ~38,000 claims), the strategy… Continue reading The Bard Hernia Mesh Landscape in 2026
Bard Hernia Mesh Litigation Covidien Litigation Hernia Mesh Update
The “Hernia Mesh” bucket is no longer a single asset class
January 21, 2026 by Mohr Marketing Mohr Marketing Launches “Post-Settlement” Protocol for Bard Mesh; Opens New Acquisition Channels for Emerging Covidien Litigation Dual-strategy for 2026: Strict “Tier 1” filtration for mature Bard dockets and aggressive growth focus for Covidien (MDL 3029). Mohr Marketing, a specialized digital agency for the legal sector, today announced a strategic overhaul of its hernia mesh acquisition… Continue reading The “Hernia Mesh” bucket is no longer a single asset class
Bard Hernia Mesh Litigation Covidien Litigation Hernia Mesh Update
Intake Protocol to Navigate Stricter 2026 Bard Hernia Mesh Docket
January 21, 2026 by Mohr Marketing Mohr Marketing Launches “Post-Settlement” Intake Protocol to Navigate Stricter 2026 Bard Hernia Mesh Docket Control Mohr Marketing, a specialized digital agency for the legal sector, today announced the launch of its “Tier 1” Bard Intake Protocol, a proprietary acquisition program designed specifically for the post-settlement administration phase of the C.R. Bard Hernia Mesh litigation (MDL… Continue reading Intake Protocol to Navigate Stricter 2026 Bard Hernia Mesh Docket
Bard Hernia Mesh Litigation Covidien Litigation Hernia Mesh Update
The 2026 MVA Lead Generation Compliance Checklist
January 20, 2026 by Mohr Marketing Protecting Your Firm from Barratry, Capping, and Ethical Violations in the AI Era Disclaimer: This checklist is for informational purposes only and does not constitute legal advice. Attorneys should always consult their specific State Bar rules regarding advertising and solicitation. Part 1: The “Source & Origin” Test How is the lead generated? This is the… Continue reading The 2026 MVA Lead Generation Compliance Checklist
Compliance Shield
⚠️ Your “Inventory” might be at risk (Read this)
January 19, 2026 by Mohr Marketing Why “Brokered” Mass Tort cases are becoming a liability. Switch to Direct AI Acquisition. In the high-stakes world of Mass Torts, “Data Integrity” is the new gold. If you are building your docket by purchasing “signed cases” from third-party aggregators, you are facing three major risks: Dual Representation: The claimant has already been sold to… Continue reading ⚠️ Your “Inventory” might be at risk (Read this)
Mass Tort Lead Generation
Recent Posts
Categories
Archives

Copyright © 1994-2025 Mohr Marketing, LLC. All Rights Reserved.

Secret Link